Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
Health Catalyst (HCAT) Stock Price & Analysis
419 Followers
HCAT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.45 - $14.37
Previous Close$7.26
Volume459.15K
Average Volume (3M)583.69K
Market Cap
$428.59M
Enterprise Value$349.68M
Total Cash (Recent Filing)$327.79M
Total Debt (Recent Filing)$248.87M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Aug 01, 2024EPS Estimate
$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.85
Shares Outstanding59,034,936
10 Day Avg. Volume351,546
30 Day Avg. Volume583,686
Standard Deviation0.15
R-Squared0.23
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)3.61
Price to Sales (P/S)4.82
Price to Cash Flow (P/CF)8.80
P/FCF Ratio9.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.29
Enterprise Value/Gross Profit2.65
Enterprise Value/Ebitda-4.43
Forecast
1Y Price Target
$11.00Price Target Upside48.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Health Catalyst News
Bulls Say, Bears Say
Bulls Say
Client GrowthInterest in the updated platform from both existing and potential new clients could portend growth acceleration and improved margins longer term.
Debt ManagementHCAT's net cash cushion may allow management to either fully extinguish its debt or downsize a follow-on debt offering into conventional senior secured debt.
Product LaunchHCAT formally launched its Ignite tech platform, combining technology from Databricks, Microsoft, and Snowflake, which will bring significant flexibility to HCAT’s go-to-market strategy.
Bears Say
Client BankruptcyA client undergoing bankruptcy proceedings may contribute to short-term overhang for the stock.
Convertible DebtConvertible debt maturing is making the market reluctant to bid on the stock given the uncertainty about HCAT's refinancing path.
Profit MarginsTEMS contracting going live is expected to pressure second half Professional Services margins.
---
Ownership Overview
21.67% Insiders
30.17% Mutual Funds
14.74% Other Institutional Investors
33.42% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $5.45 and its highest was $14.37 in the past 12 months.
What is Health Catalyst’s market cap?
Currently, no data Available
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Aug 01, 2024 which is in 9 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on May 09, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.031 by $0.019.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is $0.08.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 59,034,935 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.05 in its last earnings report, beating expectations of $0.031. Following the earnings report the stock price went down -3.898%.
Which hedge fund is a major shareholder of Health Catalyst?
Among the largest hedge funds holding Health Catalyst’s share is PRIMECAP Management Co. It holds Health Catalyst’s shares valued at 16M.
---
Health Catalyst Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (48.85% Upside)
$11.00 (48.85% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 707.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.05%
12-Months-Change
Fundamentals
Return on Equity
-27.69%
Trailing 12-Months
Asset Growth
-7.60%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in Salt Lake City, UT.
---
HCAT Earnings Call
Q1 2024
0:00 / 0:00
---
HCAT Stock 12 Month Forecast
Average Price Target
$11.00
▲(48.85% Upside)
Technical Analysis
Best Analysts Covering HCAT
1 Year
1 Year Success Rate
5/16 ratings generated profit
1 Year Average Return
-12.94%
reiterated a buy rating 2 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of -12.94% per trade.
---